RetinalGenix Technologies (RTGN) Free Cash Flow (2020 - 2026)
RetinalGenix Technologies recorded quarterly Free Cash Flow of -$109213.0 in Q1 2026, up 14.82% quarter-over-quarter from -$128219.0 in Q4 2025, and up 41.67% year-over-year from -$77091.6 in Q1 2025.
RetinalGenix Technologies' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$109213.0 for Q1 2026.
- In Q1 2026, Free Cash Flow rose 41.67% year-over-year to -$109213.0; the TTM figure through Mar 2026 stood at -$480341.0 (up 37.24% YoY), while the FY2025 annual figure was -$558350.0, up 24.74% from the prior year.
- Free Cash Flow came in at -$109213.0 for Q1 2026 at RetinalGenix Technologies, up from -$128219.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $39749.0 in Q3 2023 to a low of -$290025.0 in Q4 2023.
- A 5-year average of -$121202.8 and a median of -$123810.0 in 2023 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 167.42% in 2023 and fell as far as 1100.41% in 2023.
- RetinalGenix Technologies' Free Cash Flow stood at -$33225.0 in 2022, then tumbled by 772.91% to -$290025.0 in 2023, then surged by 35.73% to -$186390.0 in 2024, then jumped by 31.21% to -$128219.0 in 2025, then grew by 14.82% to -$109213.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$109213.0, -$128219.0, and -$103837.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | RetinalGenix Technologies | - | - | - | -109,213.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109,213.00 |
| Mar 31, 2026 | -109,213.00 |
| Dec 31, 2025 | -128,219.00 |
| Dec 31, 2025 | -128,219.00 |
| Sep 30, 2025 | -103,837.00 |
| Sep 30, 2025 | -103,837.00 |
| Jun 30, 2025 | -139,072.00 |
| Jun 30, 2025 | -139,072.00 |
| Mar 31, 2025 | -187,222.00 |
| Mar 31, 2025 | -187,222.00 |
| Dec 31, 2024 | -186,390.00 |
| Dec 31, 2024 | -186,390.00 |
| Sep 30, 2024 | -246,932.00 |
| Sep 30, 2024 | -246,932.00 |
| Jun 30, 2024 | -144,795.00 |
| Jun 30, 2024 | -144,795.00 |
| Mar 31, 2024 | -163,819.00 |
| Mar 31, 2024 | -163,819.00 |
| Dec 31, 2023 | -290,025.00 |
| Dec 31, 2023 | -290,025.00 |
| Sep 30, 2023 | 39,749.00 |
| Sep 30, 2023 | 39,749.00 |
| Jun 30, 2023 | -123,810.00 |
| Jun 30, 2023 | -123,810.00 |
| Mar 31, 2023 | -77,575.00 |
| Mar 31, 2023 | -77,575.00 |
| Dec 31, 2022 | -33,225.00 |
| Dec 31, 2022 | -33,225.00 |
| Sep 30, 2022 | -58,956.00 |
| Sep 30, 2022 | -58,956.00 |
| Jun 30, 2022 | -10,314.00 |
| Jun 30, 2022 | -10,314.00 |
| Mar 31, 2022 | -96,792.00 |
| Mar 31, 2022 | -96,792.00 |
| Dec 31, 2021 | -290,565.00 |
| Dec 31, 2021 | -290,565.00 |
| Sep 30, 2021 | -212,680.00 |
| Sep 30, 2021 | -212,680.00 |
| Jun 30, 2021 | -264,495.00 |
| Jun 30, 2021 | -264,495.00 |
| Mar 31, 2021 | -399,231.00 |
| Mar 31, 2021 | -399,231.00 |
| Dec 31, 2020 | -371,681.00 |
| Dec 31, 2020 | -371,681.00 |